Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
Opus Genetics, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD),…
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
Opus Genetics, Inc. Robert Gagnon, CFO, Opus Genetics Robert Gagnon, CFO, Opus Genetics RESEARCH TRIANGLE PARK, N.C., Sept.…
Opus Genetics’ BEST1 Gene Therapy IND Cleared by FDA
Opus Genetics (Nasdaq: IRD) has received FDA clearance for its…